Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Comparison of Clinical Characteristics of JAK2, CALR and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2024

Li Yu-Meng, Yang Er-Peng, Wang Zi-Qing, Wang De-Hao, Niu Ji-Cong, Li Yu-Jin, Ming Jing, Sun Ming-Qian, Chen Zhuo, Liu Wei-Yi, Lyu Yan, Hu Xiao-Mei

Abstract excerpt

OBJECTIVE: To investigate the relationship between mutated genes and clinical features in patients with essential thrombocythemia (ET). METHODS: The clinical data of 69 patients with ET from October 2018 to March 2022 were retrospectively analyzed. According to driver mutation type, patients were divided into JAK2 group, CALR group and triple-negative group. The sex, age, cardiovascular risk factors, thrombosis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Splenomegaly

Share to Thrombocythemia, Essential

Share to Thrombosis

Source

Identifiers

PMID: 38387921
DOI: 10.19746/j.cnki.issn.1009-2137.2024.01.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Comparison of Clinical Characteristics of JAK2, CALR and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia].PMID 38387921Read ↗

[Gene mutation spectrum and clinical characteristics analysis of 178 patients with essential thrombocytosis].Semantic proximity Read ↗

JAK2 or CALR Mutations Status and Bone Marrow Histology in Patients with Essential Thrombocythemia in ChineseSemantic proximity Read ↗

One thousand patients with essential thrombocythemia: the Mayo Clinic experience.Semantic proximity Read ↗

Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia.Semantic proximity Read ↗

JAK2V617F, CALR and MPL515L/K mutations and plateletcrit in essential thrombocythemia: A single centre's experience.Semantic proximity Read ↗

[Clinical Characteristics and Bone Marrow Histopathology Features in Essential Thrombocythaemia Patients with Different Gene Mutation in China].Semantic proximity Read ↗

One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.Semantic proximity Read ↗

[Clinical Analysis of 66 Patients with Essential Thrombocytopenia].Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].Semantic proximity Read ↗

Clinical and molecular characteristics of forty Chinese children with essential thrombocythemia: A single-center, retrospective analysis.Semantic proximity Read ↗

Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.